The salivary scavenger and agglutinin in early life: Diverse roles in amniotic fluid and in the infant intestine

Journal of Immunology

Volumn 193, Issue 10, 2014, Pages 5240-5248

  Reichhardt, Martin Parnov ^a,b   Jarva, Hanna ^a,b,c   De Been, Mark ^b,d   Rodriguez, Juan Miguel ^e   Quintana, Esther Jimenez ^f   Loimaranta, Vuokko ^g   De Vos, Willem Meindert ^a,d,g   Meri, Seppo ^a,b,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^f UNIVERSITY OF TURKU   (Finland)

^g WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLUTININ; COMPLEMENT COMPONENT C1Q; MANNOSE BINDING LECTIN; SALIVA PROTEIN; SALIVARY SCAVENGER AND AGGLUTININ PROTEIN; SECRETORY IMMUNOGLOBULIN; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; DMBT1 PROTEIN, HUMAN; IMMUNOGLOBULIN A; PEPTIDE FRAGMENT; PROTEIN BINDING;

AMNION FLUID; ARTICLE; BACTERIAL COLONIZATION; BINDING AFFINITY; CELL DIFFERENTIATION; CONTROLLED STUDY; ESCHERICHIA COLI; FECES ANALYSIS; FETUS DEVELOPMENT; HUMAN; IMMUNOLOGICAL TECHNIQUE; INFANT; INNATE IMMUNITY; INTESTINE MUCOSA; MASS SPECTROMETRY; MECONIUM; OLIGOMERIZATION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS GORDONII; STREPTOCOCCUS PYOGENES; ZONA PELLUCIDA; AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; CHEMICAL STRUCTURE; CHEMISTRY; GENE EXPRESSION; IMMUNOLOGY; INTESTINE; METABOLISM; MOLECULAR GENETICS; MUCOSAL IMMUNITY; NEWBORN; PEPTIDE MAPPING; PROTEIN TERTIARY STRUCTURE; STREPTOCOCCUS;

AMINO ACID SEQUENCE; AMNIOTIC FLUID; COMPLEMENT C1Q; ESCHERICHIA COLI; GENE EXPRESSION; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; INFANT, NEWBORN; INTESTINES; MANNOSE-BINDING LECTIN; MECONIUM; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; PEPTIDE FRAGMENTS; PEPTIDE MAPPING; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CELL SURFACE; STREPTOCOCCUS;

EID: 84910153749     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401631     Document Type: Article

References (48)

1. Tlaskalová-Hogenová, H., R. Stepánková, T. Hudcovic, L. Tucková, B. Cukrowska, R. Lodinová-Zádníková, H. Kozáková, P. Rossmann, J. Bártová, D. Sokol, et al. 2004. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol. Lett. 93: 97-108.
2. Castro-Sánchez, P., and J. M. Martín-Villa. 2013. Gut immune system and oral tolerance. Br. J. Nutr. 109(Suppl 2): S3-S11.
3. Adkins, B., C. Leclerc, and S. Marshall-Clarke. 2004. Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 4: 553-564.
4. Levy, O. 2007. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 7: 379-390.
5. Karlsson, H., C. Hessle, and A. Rudin. 2002. Innate immune responses of human neonatal cells to bacteria from the normal gastrointestinal flora. Infect. Immun. 70: 6688-6696.
6. McDonagh, S., E. Maidji, W. Ma, H. T. Chang, S. Fisher, and L. Pereira. 2004. Viral and bacterial pathogens at the maternal-fetal interface. J. Infect. Dis. 190: 826-834.
7. Holmskov, U., P. Lawson, B. Teisner, I. Tornoe, A. C. Willis, C. Morgan, C. Koch, and K. B. Reid. 1997. Isolation and characterization of a new member of the scavenger receptor superfamily, glycoprotein-340 (gp-340), as a lung surfactant protein-D binding molecule. J. Biol. Chem. 272: 13743-13749.
8. Mollenhauer, J., S. Wiemann, W. Scheurlen, B. Korn, Y. Hayashi, K. K. Wilgenbus, A. von Deimling, and A. Poustka. 1997. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nat. Genet. 17: 32-39.
9. Holmskov, U., J. Mollenhauer, J. Madsen, L. Vitved, J. Gronlund, I. Tornoe, A. Kliem, K. B. Reid, A. Poustka, and K. Skjodt. 1999. Cloning of gp-340, a putative opsonin receptor for lung surfactant protein D. Proc. Natl. Acad. Sci. USA 96: 10794-10799.
10. Mollenhauer, J., S. Herbertz, U. Holmskov, M. Tolnay, I. Krebs, A. Merlo, H. D. Schrøder, D. Maier, F. Breitling, S.Wiemann, et al. 2000. DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer. Cancer Res. 60: 1704-1710.
11. Mollenhauer, J., S. Herbertz, B. Helmke, G. Kollender, I. Krebs, J. Madsen, U. Holmskov, K. Sorger, L. Schmitt, S. Wiemann, et al. 2001. Deleted in Malignant Brain Tumors 1 is a versatile mucin-like molecule likely to play a differential role in digestive tract cancer. Cancer Res. 61: 8880-8886.
12. Kang, W., O. Nielsen, C. Fenger, J. Madsen, S. Hansen, I. Tornoe, P. Eggleton, K. B. Reid, and U. Holmskov. 2002. The scavenger receptor, cysteine-rich domain-containing molecule gp-340 is differentially regulated in epithelial cell lines by phorbol ester. Clin. Exp. Immunol. 130: 449-458.
13. Stoddard, E., G. Cannon, H. Ni, K. Karikó, J. Capodici, D. Malamud, and D. Weissman. 2007. gp340 expressed on human genital epithelia binds HIV-1 envelope protein and facilitates viral transmission. J. Immunol. 179: 3126-3132.
14. Schulz, B. L., D. Oxley, N. H. Packer, and N. G. Karlsson. 2002. Identification of two highly sialylated human tear-fluid DMBT1 isoforms: the major highmolecular-mass glycoproteins in human tears. Biochem. J. 366: 511-520.
15. Grønborg, M., J. Bunkenborg, T. Z. Kristiansen, O. N. Jensen, C. J. Yeo, R. H. Hruban, A. Maitra, M. G. Goggins, and A. Pandey. 2004. Comprehensive proteomic analysis of human pancreatic juice. J. Proteome Res. 3: 1042-1055.
16. Nagashunmugam, T., D. Malamud, C. Davis, W. R. Abrams, and H. M. Friedman. 1998. Human submandibular saliva inhibits human immunodeficiency virus type 1 infection by displacing envelope glycoprotein gp120 from the virus. J. Infect. Dis. 178: 1635-1641.
17. Prakobphol, A., F. Xu, V. M. Hoang, T. Larsson, J. Bergstrom, I. Johansson, L. Frängsmyr, U. Holmskov, H. Leffler, C. Nilsson, et al. 2000. Salivary agglutinin, which binds Streptococcus mutans and Helicobacter pylori, is the lung scavenger receptor cysteine-rich protein gp-340. J. Biol. Chem. 275: 39860-39866.
18. Hartshorn, K. L., M. R. White, T. Mogues, T. Ligtenberg, E. Crouch, and U. Holmskov. 2003. Lung and salivary scavenger receptor glycoprotein-340 contribute to the host defense against influenza A viruses. Am. J. Physiol. Lung Cell. Mol. Physiol. 285: L1066-L1076.
19. Bikker, F. J., A. J. Ligtenberg, C. End, M. Renner, S. Blaich, S. Lyer, R. Wittig, W. van't Hof, E. C. Veerman, K. Nazmi, et al. 2004. Bacteria binding by DMBT1/SAG/gp-340 is confined to the VEVLXXXXW motif in its scavenger receptor cysteine-rich domains. J. Biol. Chem. 279: 47699-47703.
20. Loimaranta, V., N. S. Jakubovics, J. Hytönen, J. Finne, H. F. Jenkinson, and N. Strömberg. 2005. Fluid-or surface-phase human salivary scavenger protein gp340 exposes different bacterial recognition properties. Infect. Immun. 73: 2245-2252.
21. Leito, J. T., A. J. Ligtenberg, K. Nazmi, J. M. de Blieck-Hogervorst, E. C. Veerman, and A. V. Nieuw Amerongen. 2008. A common binding motif for various bacteria of the bacteria-binding peptide SRCRP2 of DMBT1/gp-340/ salivary agglutinin. Biol. Chem. 389: 1193-1200.
22. Loimaranta, V., J. Hytönen, A. T. Pulliainen, A. Sharma, J. Tenovuo, N. Strömberg, and J. Finne. 2009. Leucine-rich repeats of bacterial surface proteins serve as common pattern recognition motifs of human scavenger receptor gp340. J. Biol. Chem. 284: 18614-18623.
23. Jonasson, A., C. Eriksson, H. F. Jenkinson, C. Källestål, I. Johansson, and N. Strömberg. 2007. Innate immunity glycoprotein gp-340 variants may modulate human susceptibility to dental caries. BMC Infect. Dis. 7: 57-65.
24. Rosenstiel, P., C. Sina, C. End, M. Renner, S. Lyer, A. Till, S. Hellmig, S. Nikolaus, U. R. Fölsch, B. Helmke, et al. 2007. Regulation of DMBT1 via NOD2 and TLR4 in intestinal epithelial cells modulates bacterial recognition and invasion. J. Immunol. 178: 8203-8211.
25. Rundegren, J., and R. R. Arnold. 1987. Differentiation and interaction of secretory immunoglobulin A and a calcium-dependent parotid agglutinin for several bacterial strains. Infect. Immun. 55: 288-292.
26. Tino, M. J., and J. R. Wright. 1999. Glycoprotein-340 binds surfactant protein-A (SP-A) and stimulates alveolar macrophage migration in an SP-A-independent manner. Am. J. Respir. Cell Mol. Biol. 20: 759-768.
27. Thornton, D. J., J. R. Davies, S. Kirkham, A. Gautrey, N. Khan, P. S. Richardson, and J. K. Sheehan. 2001. Identification of a nonmucin glycoprotein (gp-340) from a purified respiratory mucin preparation: evidence for an association involving the MUC5B mucin. Glycobiology 11: 969-977.
28. Reichhardt, M. P., V. Loimaranta, S. Thiel, J. Finne, S. Meri, and H. Jarva. 2012. The salivary scavenger and agglutinin binds MBL and regulates the lectin pathway of complement in solution and on surfaces. Front. Immunol. 3: 205-215.
29. Takito, J., L. Yan, J. Ma, C. Hikita, S. Vijayakumar, D. Warburton, and Q. Al-Awqati. 1999. Hensin, the polarity reversal protein, is encoded by DMBT1, a gene frequently deleted in malignant gliomas. Am. J. Physiol. 277: F277-F289.
30. Madsen, J., I. Tornøe, O. Nielsen, M. Lausen, I. Krebs, J. Mollenhauer, G. Kollender, A. Poustka, K. Skjødt, and U. Holmskov. 2003. CRP-ductin, the mouse homologue of gp-340/deleted in malignant brain tumors 1 (DMBT1), binds gram-positive and gram-negative bacteria and interacts with lung surfactant protein D. Eur. J. Immunol. 33: 2327-2336.
31. Mollenhauer, J., U. Holmskov, S. Wiemann, I. Krebs, S. Herbertz, J. Madsen, P. Kioschis, J. F. Coy, and A. Poustka. 1999. The genomic structure of the DMBT1 gene: evidence for a region with susceptibility to genomic instability. Oncogene 18: 6233-6240.
32. Oho, T., H. Yu, Y. Yamashita, and T. Koga. 1998. Binding of salivary glycoprotein-secretory immunoglobulin A complex to the surface protein antigen of Streptococcus mutans. Infect. Immun. 66: 115-121.
33. Eriksson, C., L. Frängsmyr, L. Danielsson Niemi, V. Loimaranta, U. Holmskov, T. Bergman, H. Leffler, H. F. Jenkinson, and N. Strömberg. 2007. Variant sizeand glycoforms of the scavenger receptor cysteine-rich protein gp-340 with differential bacterial aggregation. Glycoconj. J. 24: 131-142.
34. Kolmeder, C. A., M. de Been, J. Nikkilä, I. Ritamo, J. Mättö, L. Valmu, J. Salojärvi, A. Palva, A. Salonen, and W. M. de Vos. 2012. Comparative metaproteomics and diversity analysis of human intestinal microbiota testifies for its temporal stability and expression of core functions. PLoS ONE 7: e29913.
35. Lu, J., S. Boeren, S. C. de Vries, H. J. van Valenberg, J. Vervoort, and K. Hettinga. 2011. Filter-aided sample preparation with dimethyl labeling to identify and quantify milk fat globule membrane proteins. J. Proteomics 75: 34-43.
36. Brace, R. A. 1997. Physiology of amniotic fluid volume regulation. Clin. Obstet. Gynecol. 40: 280-289.
37. Hohenester, E., T. Sasaki, and R. Timpl. 1999. Crystal structure of a scavenger receptor cysteine-rich domain sheds light on an ancient superfamily. Nat. Struct. Biol. 6: 228-232.
38. Han, L., M. Monné, H. Okumura, T. Schwend, A. L. Cherry, D. Flot, T. Matsuda, and L. Jovine. 2010. Insights into egg coat assembly and egg-sperm interaction from the X-ray structure of full-length ZP3. Cell 143: 404-415.
39. Plaza, S., H. Chanut-Delalande, I. Fernandes, P. M. Wassarman, and F. Payre. 2010. From A to Z: apical structures and zona pellucida-domain proteins. Trends Cell Biol. 20: 524-532.
40. Al-Awqati, Q., S. Vijayakumar, and J. Takito. 2003. Terminal differentiation of epithelia from trophectoderm to the intercalated cell: the role of hensin. J. Am. Soc. Nephrol. 14(Suppl 1): S16-S21.
41. Al-Awqati, Q., S. Vijayakumar, J. Takito, C. Hikita, L. Yan, and T. Wiederholt. 1999. Terminal differentiation in epithelia: the Hensin pathway in intercalated cells. Semin. Nephrol. 19: 415-420.
42. Takito, J., and Q. Al-Awqati. 2004. Conversion of ES cells to columnar epithelia by hensin and to squamous epithelia by laminin. J. Cell Biol. 166: 1093-1102.
43. Simonsen, K. A., A. L. Anderson-Berry, S. F. Delair, and H. D. Davies. 2014. Early-onset neonatal sepsis. Clin. Microbiol. Rev. 27: 21-47.
44. An, H. J., T. R. Peavy, J. L. Hedrick, and C. B. Lebrilla. 2003. Determination of N-glycosylation sites and site heterogeneity in glycoproteins. Anal. Chem. 75: 5628-5637.
45. Whiteaker, J. R., L. Zhao, L. Anderson, and A. G. Paulovich. 2010. An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers. Mol. Cell. Proteomics 9: 184-196.
46. Koshikawa, N., S. Hasegawa, Y. Nagashima, K. Mitsuhashi, Y. Tsubota, S. Miyata, Y. Miyagi, H. Yasumitsu, and K. Miyazaki. 1998. Expression of trypsin by epithelial cells of various tissues, leukocytes, and neurons in human and mouse. Am. J. Pathol. 153: 937-944.
47. Madsen, J., G. L. Sorensen, O. Nielsen, I. Tornøe, L. Thim, C. Fenger, J. Mollenhauer, and U. Holmskov. 2013. A variant form of the human deleted in malignant brain tumor 1 (DMBT1) gene shows increased expression in inflammatory bowel diseases and interacts with dimeric trefoil factor 3 (TFF3). PLoS ONE 8: e64441.
48. Müller, H., C. End, C. Weiss, M. Renner, A. Bhandiwad, B. M. Helmke, N. Gassler, M. Hafner, A. Poustka, J. Mollenhauer, and J. Poeschl. 2008. Respiratory Deleted in Malignant Brain Tumours 1 (DMBT1) levels increase during lung maturation and infection. Clin. Exp. Immunol. 151: 123-129.